Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBOMESA: 5-ASA + Corticosteroids in Severe UC
NCT02665845Phase 3Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Jun 2016
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of Salcrozine in ulcerative colitis (UC), sponsored by CHU Saint-Etienne. Started Jun 2016; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02665845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02665845.